Religiosity in patients with Parkinson's disease

Neuropsychiatric Disease and Treatment

Volumn 2, Issue 3, 2006, Pages 341-348

  McNamara, Patrick ^a,b,c   Durso, Raymon ^a,b   Brown, Ariel ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Dopamine agonists; Executive functions; Mood; Neuropsychology; Parkinson's disease; Religiosity

Indexed keywords

CARBIDOPA PLUS LEVODOPA; PRAMIPEXOLE;

ADULT; AGED; ANXIETY; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COGNITION; CORRELATIONAL STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DOSE CALCULATION; FEMALE; HUMAN; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; MOOD; MOTIVATION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PATIENT ATTITUDE; PREFRONTAL CORTEX; RECALL; RELIGION;

EID: 33750004444     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/nedt.2006.2.3.341     Document Type: Article

References (39)

1. Agid Y, Javoy-Agid M, Ruberg M. 1987. Biochemistry of neurotransmitters in Parkinson's disease. In Marsden CD, Fahn S (eds). Movement Disorders 2. New York: Butterworth and Co.
2. Antonini A, Vontobel R, Psylla M, et al. 1995. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Arch Neurol, 52:1183-90.
3. Antony MM, Bieling PJ, Cox BJ, et al. 1998. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales (DASS) in clinical groups and a community sample. Psychol Assess, 10:176-81.
4. Azari NP, Nickel J. 2001. Neural correlates of religious experience. Eur J Neurosci, 13:1649-52.
5. Batson CD, Shoenrade P, Ventis WL. 1993. Religion and the individual: A social-psychological perspective. New York: Oxford University Press.
6. Bench CJ, Frith CD, Grasby PM, et al. 1993. Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia, 31:907-22.
7. Booij J, Tissingh G, Boer GJ, et al. 1997. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labeling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry, 62:133-40.
8. Comings DE, Gonzales N, Saucier G, et al. 2000. The DRD4 gene and the spiritual transcendence scale of the character temperament index. Psychiatr Genet, 10:185-9.
9. Crawford JR, Henry JD. 2003. The Depression Anxiety Stress Scales (DASS):normative data and latent structure in a large non-clinical sample. Br J Clin Psychol, 42:111-31.
10. d'Aquili E, Newberg A. 1999. The Mystical Mind:Probing the Biology of Religious Experience. Minneapolis, MN: Fortress Press.
11. Dewhurst K, Beard AW. 1970. Sudden religious conversions in temporal lobe epilepsy. Br J Psychiatry, 117:497-507.
12. Emmons RA, Paloutzian RF. 2003. The psychology of religion. Ann Rev Psychol, 54:377-402.
13. Fetzer Institute. 1999. Multidimensional measurement of religiousness/ spirituality for use in health research. Bethesda, MD: Fetzer Institute, National Institute of Aging. p 1-95.
14. Geschwind N. 1983. Interictal behavioral changes in epilepsy. Epilepsia, 24(Suppl 1):S23-30.
15. Hamer DH. 2004. The god gene: How faith is hardwired into our genes. New York: Doubleday.
16. Hoehn MM, Yahr MD. 2001. Parkinsonism: onset, progression, and mortality. 1967. Neurology, 57:S11-26.
17. Kempster PA, Gibb WR, Stern GM, et al. 1989. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry, 52:72-6.
18. Leenders KL, Salmon EP, Tyrrell P. 1990. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol, 47:1290-8.
19. Lezak, MD 1995. Neuropsychological assessment. New York: Oxford University Press.
20. Lovibond SH, Lovibond PF. 1995. Manual for the depression anxiety stress scales. Sydney: The Psychology Foundation of Australia.
21. McNamara P. 2001. Religion and the frontal lobes. In Andresen J (ed). Religion in mind. Cambridge: Cambridge University Press. p 237-56.
22. McNamara P, Andresen J, Gellard J. 2003. Relation of religiosity and scores on fluency tests to subjective reports of health in older individuals. Int J Psychol Relig, 13:259-71.
23. Morris RG, Ahmed S, Syed, GM, et al. 1993. Neural correlates of planning ability:frontal lobe activation during the Tower of London test. Neuropsychologia, 31:1367-78.
24. Mozley PD, Schneider JS, Acton PD. 2000. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nuclear Med, 41:584-9.
25. Nair KP, Wade DT. 2003. Changes in life goals of people with neurological disabilities. Clin Rehabil, 17:797-803.
26. Newberg A, Alavi A, Baime M, et al. 1997. The measurement of cerebral blood flow during the complex cognitive task of meditation using HMPAO-SPECT imaging. J Nuclear Med, 38:95.
27. Newberg A, Alavi A, Baime M. 2001. The measurement of regional cerebral blood flow during the complex cognitive task of meditation:a preliminary SPECT study. Psychiatry Res, 106:113-22.
28. Ramachandran VS, Hirstein WS, Armel KC, et al. 1997. The neural basis of religious experience. 27th Annual Meeting of the Society for Neuroscience. New Orleans, LA.
29. Raven JC. 1965. Guide to using the coloured progressive matrices. London: H. K. Lewis.
30. Razmy A, Lang AE, Shapiro CM. 2004. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol, 61:97-102.
31. Shallice T. 1982. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci, 298:199-209.
32. Siddle R, Haddock G, Tarrier N, et al. 2002. Religious delusions in patients admitted to hospital with schizophrenia. Soc Psychiatry Psychiatr Epidemiol, 37:130-8.
33. Starkstein SE, Merello M. 2002. Psychiatric and cognitive disorders in Parkinson's disease. Cambridge: Cambridge University Press
34. Stroop J. 1935. Studies of interference in serial verbal interactions. J Exp Psych, 18:643-62.
35. Taylor AE, Saint-Cyr JA. 1995. The neuropsychology of Parkinson's disease. Brain Cogn, 28:281-96.
36. Tek C, Ulug B. 2001. Religiosity and religious obsessions in obsessive-compulsive disorder. Psychiatry Res, 104:99-108.
37. Tissingh G, Bergmans P, Booij J, et al. 1998. Drug-naïve patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT. J Neurol, 245:14-20.
38. Vendrell P, Junque C, Pujol J. 1995. The role of prefrontal regions in the Stroop task. Neuropsychologia, 33:341-52.
39. Wechsler D. 1987. Wechsler Memory Scale - Revised manual. San Antonio, TX: The Psychological Corporation.